The altered pattern of CSF protein levels usually seen in patients with AD is also present in MCI (especially in patients who will convert to AD): high levels of t-Tau and/or p-Tau and decreased Aβ42 levels [65]. The gene discussed is MAPT; the disease is Alzheimer disease.